DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Digital Insights (1048)

Best Practices for Patient Digital Engagement | EU5 | 2017

Best Practices for Patient Digital Engagement | EU5 | 2017

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

Engaging patients and caregivers online in the EU5 is challenging for pharma. Restrictions on direct-to-consumer promotion are significantly greater in the EU than in the US, making the task faced by digital marketers in the EU that much tougher and complicating the business case for using digital to drive awareness and prescription requests.



Organizations have looked towards different channels to engage and educate consumers over the last few years, leading to innovations in design and experience, ways to add value through support and integration of offline campaigns into digital media.



This report is designed to help marketers assess how sophisticated the marketplace of consumer-facing digital resources from pharma in the EU is, how brands are innovating in this space, and which markets and therapy areas are most competitive.


Questions Answered in This Report:

    • Is there a need for investing in digital solutions for EU5 consumers?
    • How are pharma companies investing in consumer-facing websites in the EU5?  What are the different models utilized to engage with patients within this digital ecosystem?
    • What sorts of content and features are offered by pharma on various websites? What does innovation look like in this space? Where are there unmet consumer needs and opportunities to maximize value?
    • Which markets and therapy areas see relatively more aggressive digital investment from pharma?
  • Pub Date: November 2017

Request report

Related reports:
You may also be interested in: